Pacer Advisors
SPPI

Pacer Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Pacer Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,670
Closed -$45K – 1585
2021
Q1 		$45K Buy
13,670
+540
+4% +$1.94K ﹤0.01% 1453
2020
Q4 		$45K Buy
13,130
+7,022
+115% +$28.9K ﹤0.01% 1426
2020
Q3 		$25K Buy
+6,108
New +$23.2K ﹤0.01% 1348
2018
Q4 		– Sell
-11,999
Closed -$202K – 1103
2018
Q3 		$202K Buy
+11,999
New +$260K 0.01% 1029
2018
Q1 		– Sell
-1,407
Closed -$27K – 1141
2017
Q4 		$27K Buy
+1,407
New +$25.5K ﹤0.01% 1078

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Pacer Advisors's SPPI Position: Q2 2021 in Review

Pacer Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2021, closing a stake of 13,670 shares — an estimated $45K sold.

Pacer Advisors first reported a position in SPPI in Q4 2017 and held it in 5 quarters. The position peaked at $202K in Q3 2018. 156 funds tracked by Wall St. Rank hold SPPI as of Q2 2021.

  • Pacer Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 13,670 Spectrum Pharmaceuticals Inc shares in Q2 2021, an estimated $45K.
  • Pacer Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q4 2017 and held it in 5 quarters.
  • Pacer Advisors's Spectrum Pharmaceuticals Inc position peaked at $202K in Q3 2018.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.